Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients

ConclusionOur findings reinforce the potential clinical value of germline variants inVEGFA andVEGFR2 and show for the first time variants inITGAV andMAPK11 as promising prognostic markers in metastatic NSCLC patients receiving platinum-based chemotherapy.

Source: Angiogenesis - April 10, 2019 Category: Molecular Biology Source Type: research